ER-positive breast cancer presents differing metabolic signatures in African American, white women
CHAMPAIGN, Ill. — New research found the most common form of breast cancer presents differing metabolic signatures in the blood ...
CHAMPAIGN, Ill. — New research found the most common form of breast cancer presents differing metabolic signatures in the blood ...
Leading executives from Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven, clinical stage drug discovery company, are presenting at two ...
A phone’s alarm wakes a person up. They turn off the alarm and start playing their morning playlist casted to ...
AUSTIN, Texas – A new statistical tool can help researchers get meaningful results when a randomized experiment, considered the gold ...
Despite decades of global population growth, global food crisis seems to be at hand yet again because the food productivity ...
“It’s a great privilege to host the World Conference of Science Journalists 2025,” says Mandi Smallhorne, president of SASJA. “As it ...
The August 2023 issue of the American Journal of Health Economics will feature a cluster of articles that examine the opioid crisis. ...
The process of converting DNA to proteins through an RNA is far from straightforward. Of the several types of RNA ...
Aneurysmal subarachnoid hemorrhage-related hydrocephalus (aSAH-H) is a clinical syndrome that leads to excessive accumulation of cerebrospinal fluid (CSF) and ventricle ...
- Of the 14 participants enrolled and treated with lenzilumab plus azacitidine, ten are evaluable with three to eighteen months ...
Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven drug discovery company, will present ...
Infections caused by fungi, such as Candida albicans, pose a significant global health risk due to their resistance to existing ...
Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven drug discovery company, will present ...
Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine (“Insilico”), a generative artificial intelligence (AI)-driven drug discovery company, will present ...
In a new study in Nature Machine Intelligence*, researchers Bojian Yin and Sander Bohté from the HBP partner Dutch National ...
Continents are part of what makes Earth uniquely habitable for life among the planets of the solar system, yet surprisingly ...
Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine (“Insilico”) will present at the 9th LSX World Congress happening in ...
WASHINGTON, D.C., April 25, 2023 – BioOne proudly announces the 2023 recipients of the BioOne Ambassador Award. Now in its sixth ...
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that four abstracts have been accepted ...
Insilico Medicine founder and CEO Alex Zhavoronkov, PhD, a pioneer in generative AI for drug discovery and in uncovering dual ...
We bring you the latest science news from best research centers and universities around the world. Check our website.
© 2023 Scienmag- Science Magazine: Latest Science News.
© 2023 Scienmag- Science Magazine: Latest Science News.